Skip to main content

Animations

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Foundation Launches $5 Million Industry-Focused Therapeutics Development Initiative

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research today announced its new Therapeutics Development Initiative, designed to promote industry programs focused on preclinical research…
    Learn more

  • Default content image

    Michael J. Fox Foundation Seeks Innovative Scientific Approaches for 2006 Community Fast Track Program

    NEWYORK, NY – The Michael J. Fox Foundation for Parkinson’s Research announced today the launch of its 2006 Community Fast Track research program (CFT ’06). This annual program aims to stimulate new…
    Learn more

  • Default content image

    Michael J. Fox Foundation Announces Funding for The California Parkinson's Disease Registry Pilot Project

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research today announced a two and a half-year grant of $200,000 to help fund the pilot portion of the California Parkinson’s Disease…
    Learn more

  • Default content image

    $1.9 Million Awarded Through Community Fast Track 2005

    NEWYORK, NY — Investigations of serotonin neurons, cellular iron levels and an approved diabetes drug are three of 15 research projects to receive nearly $1.9 million in total funding from The…
    Learn more

  • Default content image

    Eugene Johnson, PhD, to Serve as MJFF Chief Scientific Advisor

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced today that Eugene Johnson, PhD, has signed on as chief scientific advisor. Dr. Johnson is professor of molecular…
    Learn more

  • Default content image

    Parkinson’s Organizations Join to Fund Registry in Nebraska

    NEWYORK, NY — The American Parkinson Disease Association (APDA) and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) have announced that they will co-fund the Nebraska Parkinson’s…
    Learn more

  • Default content image

    Michael J. Fox Foundation Announces Funding for Ceregene Phase I Gene Therapy Clinical Trial

    NEWYORK and SAN DIEGO— The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced a three-year grant of approximately $740,000 to Ceregene, Inc., a San Diego-based biotechnology…
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.